CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Nastentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02928770
NCT02928770N/ACompleted
CompareCT.gov

A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring

Stanford University·interventional·Posted Oct 10, 2016·Updated Jan 15, 2019

In Brief

A clinical study evaluating Nastent for Obstructive Sleep Apnea and Snoring. Completed, enrolled 32 participants across 1 site.

Detailed Summary

The purpose of this research study is to test a new approach for treating patients with obstructive sleep apnea and/or snoring. The new nasal device, nastent (NAS: nasal airway stent), appears to be a useful alternative or additive treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea, Snoring
CountriesUnited States
CollaboratorsSeven Dreamers Laboratories

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 10, 2016
Enrollment StartFeb 1, 2015
Primary CompletionDec 31, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 9.7 years ago

Interventions

Nastentdevice

Use of the device while at home and in the sleep lab